These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1029790)

  • 21. [Methods of therapy of patients with chronic destructive pulmonary tuberculosis].
    Utkin VV; Rudoĭ NM
    Klin Med (Mosk); 1968 Dec; 46(12):36-43. PubMed ID: 5737381
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment results with patients with destructive pulmonary tuberculosis and their late follow-ups].
    Kalabukha AV; Kalabukha VA
    Vrach Delo; 1985 Jul; (7):41-2. PubMed ID: 4049824
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical and social aspects of chronic pulmonary tuberculosis in Finland.
    Tani P
    Scand J Respir Dis Suppl; 1970; 72():93-105. PubMed ID: 5273228
    [No Abstract]   [Full Text] [Related]  

  • 24. [Terminal causes of death in patients suffering from pulmonary tuberculosis in relation to the drug sensitivity of the strains of Mycobacterium tuberculosis].
    Daddi G; Lucchesi M; Mancini P; Rossi P; Sbampato M; Storniello G
    Ann Ist Carlo Forlanini; 1969; 29(4):339-48. PubMed ID: 5004332
    [No Abstract]   [Full Text] [Related]  

  • 25. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V; Muzikravić T
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract]   [Full Text] [Related]  

  • 26. [Why our patients have become chronic?].
    Stankov J; Haxhiu MA; Corović M; Praprotnik P; Stankov S
    Plucne Bolesti Tuberk; 1974; 26 Suppl 2():71-3. PubMed ID: 4445394
    [No Abstract]   [Full Text] [Related]  

  • 27. [On the effectiveness of rifampicin and ethambutol used in 3 different therapeutical schemes in drug-resistant chronic pulmonary tuberculosis].
    Andrian A; Ciobanu V; Cojocaru G; Borşaru I; Ciobanu D; Spirescu G; Roşianu D; Pescariu M
    Ftiziologia; 1971; 20(6):623-8. PubMed ID: 5162289
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sources of tuberculous infection in the incidence of lung tuberculosis in Middle-Bohemian Region in 1967 (author's transl)].
    Véznerová A; Polánský F
    Cesk Epidemiol Mikrobiol Imunol; 1974 May; 23(3):150-9. PubMed ID: 4280953
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of antibacterial treatment of pulmonary tuberculosis in patients with primary resistance to drugs].
    Mysakowska H; Pietroń E; Sikora-Rózyńska M; Smaga M; Litwin B; Rybicka-Stryjecka Z
    Pol Tyg Lek; 1965 May; 20(19):686-8. PubMed ID: 5844021
    [No Abstract]   [Full Text] [Related]  

  • 30. [Fate of patients with pulmonary tuberculosis and secondary drug resistance to the major drugs].
    Kost A
    Gruzlica; 1969 Nov; 37(11):997-1002. PubMed ID: 5368630
    [No Abstract]   [Full Text] [Related]  

  • 31. [Secondary drug sensitivity of tubercle bacilli in chronic sputum-positive tuberculosis patients].
    Telejko Z
    Gruzlica; 1970 Oct; 38(11):1101-4. PubMed ID: 4992233
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug-resistant tuberculosis among the homeless--Boston.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jul; 34(28):429-31. PubMed ID: 3925317
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V
    Arch Monaldi; 1972; 27(4):454-74. PubMed ID: 4217601
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of drug resistance and blood bacteriostatic activity in patients with pulmonary tuberculosis].
    Kochetov BI; Gur'ian IE
    Probl Tuberk; 1971; 49(6):64-7. PubMed ID: 5000745
    [No Abstract]   [Full Text] [Related]  

  • 35. [Epidemiological and clinical significance of resistant tuberculosis bacteria].
    Sighart H
    Wien Med Wochenschr; 1968 Oct; 118(43):923-5. PubMed ID: 4973923
    [No Abstract]   [Full Text] [Related]  

  • 36. [Which patients are dying of tuberculosis in the 90-s?].
    Vadász I; Popovics Z; Fodor T
    Orv Hetil; 1993 Oct; 134(42):2305-7. PubMed ID: 8233445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Incidence and prevalence of chronic pulmonary tuberculosis in the Cîmpulung-Argeş district 1972-1980].
    Diaconescu M; Herman PO
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(3):205-10. PubMed ID: 6296975
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Results of treatment of pulmonary tuberculosis in aged patients (after 6-years of observation)].
    Smaga M; Cyganiewicz E; Mysakowska H
    Gruzlica; 1967; 35(11):1181-6. PubMed ID: 6063622
    [No Abstract]   [Full Text] [Related]  

  • 39. Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease.
    Int J Tuberc Lung Dis; 1998 Jan; 2(1):72-89. PubMed ID: 9562116
    [No Abstract]   [Full Text] [Related]  

  • 40. [Specific serum antimycobacterial activity test in pulmonary tuberculosis patients].
    Yamagata Y; Konomata T
    Iryo; 1966 May; 20(5):450-5. PubMed ID: 5963052
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.